CapsoVision, Inc. (CV)

6.61 +0.11 (+1.69%) USD  |  NASDAQ  |  Jun 18, 16:00
6.60 -0.01 (-0.15%) After-Hours: 20:00
More

CapsoVision Research and Development Expense (Quarterly) : 4.435M for March 31, 2026

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for CV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
March 31, 2026 4.435M
December 31, 2025 5.721M
September 30, 2025 6.09M
June 30, 2025 3.392M
Date Value
March 31, 2025 3.107M
September 30, 2024 4.522M
March 31, 2024 3.26M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Accuray, Inc. 8.178M
Masimo Corp. 30.00M
ResMed, Inc. 94.27M
Rockwell Medical, Inc. --
Microbot Medical, Inc. 1.281M